Bank of New York Mellon’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-112,156
| Closed | -$655K | – | 4318 |
|
|
2025
Q1 | $655K | Buy |
112,156
+3,980
| +4% | +$21K | ﹤0.01% | 3309 |
|
|
2024
Q4 | $402K | Sell |
108,176
-1,305
| -1% | -$6.02K | ﹤0.01% | 3630 |
|
|
2024
Q3 | $612K | Sell |
109,481
-18,385
| -14% | -$129K | ﹤0.01% | 3399 |
|
|
2024
Q2 | $1.08M | Buy |
127,866
+8,673
| +7% | +$92.5K | ﹤0.01% | 3156 |
|
|
2024
Q1 | $1.72M | Sell |
119,193
-9,454
| -7% | -$156K | ﹤0.01% | 2842 |
|
|
2023
Q4 | $2.77M | Sell |
128,647
-1,886
| -1% | -$33.7K | ﹤0.01% | 2666 |
|
|
2023
Q3 | $2.51M | Buy |
130,533
+7,945
| +6% | +$169K | ﹤0.01% | 2685 |
|
|
2023
Q2 | $3.12M | Buy |
122,588
+3,084
| +3% | +$89K | ﹤0.01% | 2591 |
|
|
2023
Q1 | $4.32M | Sell |
119,504
-2,262
| -2% | -$79.4K | ﹤0.01% | 2385 |
|
|
2022
Q4 | $4.82M | Sell |
121,766
-28,088
| -19% | -$1.17M | ﹤0.01% | 2362 |
|
|
2022
Q3 | $6.98M | Sell |
149,854
-183,483
| -55% | -$8.52M | ﹤0.01% | 2116 |
|
|
2022
Q2 | $14.6M | Sell |
333,337
-13,479
| -4% | -$741K | ﹤0.01% | 1720 |
|
|
2022
Q1 | $25.1M | Sell |
346,816
-11,840
| -3% | -$854K | ﹤0.01% | 1511 |
|
|
2021
Q4 | $29.1M | Sell |
358,656
-8,905
| -2% | -$892K | 0.01% | 1498 |
|
|
2021
Q3 | $42.8M | Buy |
367,561
+5,380
| +1% | +$704K | 0.01% | 1239 |
|
|
2021
Q2 | $60M | Buy |
362,181
+4,820
| +1% | +$752K | 0.01% | 1014 |
|
|
2021
Q1 | $49.9M | Buy |
357,361
+7,145
| +2% | +$1.17M | 0.01% | 1116 |
|
|
2020
Q4 | $60.6M | Buy |
350,216
+8,850
| +3% | +$1.43M | 0.01% | 932 |
|
|
2020
Q3 | $47.6M | Buy |
341,366
+5,517
| +2% | +$737K | 0.01% | 948 |
|
|
2020
Q2 | $40.1M | Buy |
335,849
+17,054
| +5% | +$2.02M | 0.01% | 1018 |
|
|
2020
Q1 | $31.9M | Sell |
318,795
-36,779
| -10% | -$4.42M | 0.01% | 1010 |
|
|
2019
Q4 | $41.8M | Sell |
355,574
-177,988
| -33% | -$17.6M | 0.01% | 1085 |
|
|
2019
Q3 | $45.9M | Buy |
533,562
+31,314
| +6% | +$2.37M | 0.01% | 999 |
|
|
2019
Q2 | $32.6M | Buy |
502,248
+53,476
| +12% | +$3.33M | 0.01% | 1247 |
|
|
2019
Q1 | $28.1M | Sell |
448,772
-46,900
| -9% | -$2.21M | 0.01% | 1343 |
|
|
2018
Q4 | $19.3M | Buy |
495,672
+19,124
| +4% | +$850K | 0.01% | 1493 |
|
|
2018
Q3 | $27.2M | Buy |
476,548
+61,961
| +15% | +$3.87M | 0.01% | 1426 |
|
|
2018
Q2 | $33.1M | Sell |
414,587
-28,735
| -6% | -$2.38M | 0.01% | 1285 |
|
|
2018
Q1 | $38.4M | Buy |
443,322
+68,858
| +18% | +$5.56M | 0.01% | 1153 |
|
|
2017
Q4 | $25.9M | Buy |
374,464
+27,782
| +8% | +$2.22M | 0.01% | 1418 |
|
|
2017
Q3 | $31.5M | Buy |
346,682
+228,071
| +192% | +$19.5M | 0.01% | 1279 |
|
|
2017
Q2 | $8.83M | Sell |
118,611
-22,567
| -16% | -$1.81M | ﹤0.01% | 2042 |
|
|
2017
Q1 | $13.2M | Buy |
141,178
+14,601
| +12% | +$1.32M | ﹤0.01% | 1794 |
|
|
2016
Q4 | $9.2M | Sell |
126,577
-23,074
| -15% | -$1.98M | ﹤0.01% | 1999 |
|
|
2016
Q3 | $15.6M | Sell |
149,651
-6,790
| -4% | -$613K | ﹤0.01% | 1596 |
|
|
2016
Q2 | $11.5M | Buy |
156,441
+20,180
| +15% | +$1.37M | ﹤0.01% | 1770 |
|
|
2016
Q1 | $7.67M | Buy |
136,261
+1,708
| +1% | +$101K | ﹤0.01% | 1970 |
|
|
2015
Q4 | $9.09M | Buy |
134,553
+5,700
| +4% | +$305K | ﹤0.01% | 1896 |
|
|
2015
Q3 | $5.98M | Sell |
128,853
-1,856
| -1% | -$89.9K | ﹤0.01% | 2139 |
|
|
2015
Q2 | $7.03M | Buy |
130,709
+58,893
| +82% | +$3M | ﹤0.01% | 2146 |
|
|
2015
Q1 | $3.44M | Buy |
71,816
+42,623
| +146% | +$1.85M | ﹤0.01% | 2517 |
|
|
2014
Q4 | $1.13M | Buy |
+29,193
| New | +$919K | ﹤0.01% | 3239 |
|
Other funds holding NVRO
Bank of New York Mellon's NVRO Position: Q2 2025 in Review
Bank of New York Mellon sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 112,156 shares — an estimated $655K sold.
Bank of New York Mellon first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $60.6M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Bank of New York Mellon reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Bank of New York Mellon sold 112,156 NEVRO CORP. shares in Q2 2025, an estimated $655K.
- Bank of New York Mellon first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
- Bank of New York Mellon's NEVRO CORP. position peaked at $60.6M in Q4 2020.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.